IRIS
ZAMPINO, Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.837
NA - Nord America 7.476
AS - Asia 5.802
SA - Sud America 918
Continente sconosciuto - Info sul continente non disponibili 459
AF - Africa 77
OC - Oceania 4
Totale 28.573
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.957
US - Stati Uniti d'America 7.327
SG - Singapore 2.152
IE - Irlanda 1.563
CN - Cina 1.166
HK - Hong Kong 1.007
UA - Ucraina 794
BR - Brasile 763
GB - Regno Unito 659
VN - Vietnam 614
IT - Italia 553
DE - Germania 445
SE - Svezia 253
FI - Finlandia 219
TR - Turchia 192
KR - Corea 191
GR - Grecia 154
JP - Giappone 142
IN - India 123
FR - Francia 100
CA - Canada 67
AR - Argentina 61
BD - Bangladesh 53
MX - Messico 36
AT - Austria 32
EC - Ecuador 30
IQ - Iraq 27
NL - Olanda 23
ID - Indonesia 22
BE - Belgio 21
ZA - Sudafrica 17
CO - Colombia 16
MA - Marocco 16
UZ - Uzbekistan 14
VE - Venezuela 14
CL - Cile 13
PK - Pakistan 13
PL - Polonia 13
EU - Europa 12
ES - Italia 11
EG - Egitto 9
KE - Kenya 9
CR - Costa Rica 8
JM - Giamaica 8
MY - Malesia 8
SA - Arabia Saudita 8
IL - Israele 7
IR - Iran 7
LT - Lituania 7
PE - Perù 7
TN - Tunisia 7
AL - Albania 6
HN - Honduras 6
PA - Panama 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
KZ - Kazakistan 5
PH - Filippine 5
PT - Portogallo 5
SN - Senegal 5
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
LB - Libano 4
NP - Nepal 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
KG - Kirghizistan 3
KW - Kuwait 3
NI - Nicaragua 3
OM - Oman 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
CY - Cipro 2
CZ - Repubblica Ceca 2
JO - Giordania 2
PS - Palestinian Territory 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
Totale 28.112
Salva come PNG Salva come JPEG
Città #
Moscow 3.102
Dublin 1.562
Jacksonville 1.202
Santa Clara 1.027
Hong Kong 996
Singapore 849
Chandler 707
San Jose 637
Ashburn 352
Princeton 243
New York 197
Roxbury 195
Seoul 188
Ho Chi Minh City 183
Beijing 146
Hanoi 144
Ann Arbor 143
Cambridge 142
Dallas 121
Woodbridge 121
Boardman 115
Wilmington 110
Bremen 108
Hefei 105
Medford 105
The Dalles 89
Bengaluru 61
Jinan 56
São Paulo 56
San Mateo 55
Des Moines 54
Munich 52
Naples 51
Mountain View 50
Orem 50
Nanjing 48
Da Nang 46
Los Angeles 46
Düsseldorf 45
Shenyang 42
Nuremberg 41
Memphis 33
Haiphong 28
Norwalk 28
Napoli 27
Caserta 25
Chennai 24
Council Bluffs 22
Houston 22
Washington 22
Belo Horizonte 21
Bologna 21
Brussels 21
Milan 20
Changsha 19
Helsinki 19
Rio de Janeiro 19
Tokyo 19
Zhengzhou 19
Brasília 18
Guangzhou 18
Atlanta 17
Lanzhou 17
Rome 17
Tianjin 17
Toronto 17
Ningbo 16
Biên Hòa 15
Campinas 15
Frankfurt am Main 15
Amsterdam 14
Marano Di Napoli 14
Haikou 13
Hangzhou 13
Taizhou 13
Baghdad 12
Brooklyn 12
Montreal 12
Salvador 12
San Francisco 12
Seattle 12
Tashkent 12
Vienna 12
Guadalupe 11
Hebei 11
Hải Dương 11
Istanbul 11
London 11
Nanchang 11
Porto Alegre 11
Thái Bình 11
Thái Nguyên 11
Auburn Hills 10
Bari 10
Guayaquil 10
Quito 10
Warsaw 10
Casablanca 9
Dhaka 9
Manchester 9
Totale 14.572
Salva come PNG Salva come JPEG
Nome #
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 209
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 192
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 191
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 183
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 181
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 177
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 175
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 173
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 170
Chronic HCV infection and neurological and psychiatric disorders: an overview. 165
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe. 163
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 161
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe 158
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 156
Chronic hepatitis B infection in pediatric patients cured of oncologic diseases: natural history and effect of interferon treatment 155
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 152
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 152
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 151
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 151
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 150
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 150
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 150
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 150
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 149
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 149
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 149
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon 145
Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19 142
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 141
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 141
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 140
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 139
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 138
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 137
Virological patterns of HCV patients with failure to interferon-free regimens. 137
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 136
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 136
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 136
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 135
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 135
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B (HBV). 134
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 133
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 133
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 133
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant 132
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 131
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 131
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 131
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 130
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 129
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 128
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 128
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 127
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 127
HCV-related steatosis and risk of atherosclerosis 127
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 127
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 127
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays 126
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 126
Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors 124
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 124
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 123
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 123
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 122
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 122
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 122
Inotropes administration in patients with acute infective endocarditis and indication for urgent cardiac surgery 121
Viral Hepatitis C 121
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review 120
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 120
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 120
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 120
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 120
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 120
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 120
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 119
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 118
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 118
PNPLA3 I148M variant is associated with liver steatosis and fat distribution in chronic hepatitis B 118
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission 117
ESPERIENZA CON L'INTERFERONE LINFOBLASTOIDE NELLE EPATITI CRONICHE VIRALI 117
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 117
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 117
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 116
Efficacia del trattamento con interferone ricombinante e linfoblastoide in pazienti con epatite cronica da HCV. 116
Long term effect of interferon (IFN) treatment of chronic hepatitis B (CHB) in pediatric patients cured of oncologic diseases 116
Occult HBV infection in the oncohematological setting. 116
Efficacy and Safety of Fosfomycin Disodium in Patients with Bacterial Infections: A Single-Center, Real-Life Clinical Study 115
Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future 115
Effective itraconazole treatment of pulmonary aspergillosis in heart transplant patients 115
Treatment of chronic HBV infection in developing countries. 115
Drugs and liver injury: a not to be overlooked binomial in COVID-19 115
Leadless Pacemaker Infection Risk in Patients with Cardiac Implantable Electronic Device Infections: A Case Series and Literature Review 115
Embolic complications in a large contemporary cohort of infective endocarditis: do we need score model? 114
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 114
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis 114
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 114
Management of carbapenem resistant Enterobacteriaceae infections 114
Clinical correlates of circulating small dense low-density lipoproteins in acute infective endocarditis 113
Disordini immunologici in corso di epatite cronica da HCV: prevalenza significato clinico ed implicazioni terapeutiche. 113
Totale 13.493
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.609
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.387 0 13 4 14 482 19 26 44 63 149 109 464
2022/20232.898 261 48 31 222 333 222 10 165 1.467 25 56 58
2023/20241.177 93 28 41 72 420 181 34 35 6 13 88 166
2024/20253.722 8 48 32 84 589 594 560 311 443 578 322 153
2025/202614.482 461 570 677 744 1.137 8.413 737 550 517 300 252 124
2026/2027342 106 236 0 0 0 0 0 0 0 0 0 0
Totale 28.573